WuXi AppTec’s pharmaceutical facilities and analytical and stability testing facilities in Shanghai have passed the European Medicines Agency (EMA) inspection for GMP compliance, with “no critical and no major findings.” This is the third successful EMA inspection.   Inspectors from Sweden Medical Product Agency evaluated WuXi’s quality system, covering GMP small molecule drug product manufacturing, packaging and labeling, as well as GMP analytical and stability testing. The ...